Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laure Pavageau"'
Autor:
Jacques Bouget, Frédéric Balusson, Damien Viglino, Pierre-Marie Roy, Karine Lacut, Laure Pavageau, Emmanuel Oger
Publikováno v:
PLoS ONE, Vol 15, Iss 8, p e0237022 (2020)
BackgroundMajor bleedings other than gastrointestinal (GI) and intracranial (ICH) and mortality rates associated with antiplatelet drugs in real-world clinical practice are unknown. The objective was to estimate major bleeding risk and mortality amon
Externí odkaz:
https://doaj.org/article/23074b403a8741ffb550d525bc3665b8
Autor:
Jacques Bouget, Frédéric Balusson, Pierre‐Marie Roy, Damien Viglino, Laure Pavageau, Karine Lacut, Emmanuel Oger
Publikováno v:
Clinical Otolaryngology
Clinical Otolaryngology, 2023, ⟨10.1111/coa.14040⟩
Clinical Otolaryngology, 2023, ⟨10.1111/coa.14040⟩
International audience; OBJECTIVES: To describe management, and to assess factors associated with antithrombotic prescription thereafter in patients who had epistaxis referred to emergency department (ED). DESIGN: Prospective cohort study. From EDs,
Autor:
null Jacques Bouget, null Frédéric Balusson, null Pierre‐Marie Roy, null Damien Viglino, null Laure Pavageau, null Karine Lacut, null Emmanuel Oger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb5f951505f42e11e6c19da5ae38e52
https://doi.org/10.1111/coa.14040/v2/response1
https://doi.org/10.1111/coa.14040/v2/response1
Autor:
Emmanuel Oger, Lucie-Marie Scailteux, Maxime Maignan, Laure Pavageau, Jacques Bouget, Emmanuel Nowak, Karine Lacut, Pierre-Marie Roy, Frédéric Balusson
Publikováno v:
Br J Clin Pharmacol
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2020, 86 (12), pp.2519-2529. ⟨10.1111/bcp.14362⟩
British Journal of Clinical Pharmacology, 2020, 86 (12), pp.2519-2529. ⟨10.1111/bcp.14362⟩
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, Wiley, 2020, 86 (12), pp.2519-2529. ⟨10.1111/bcp.14362⟩
British Journal of Clinical Pharmacology, 2020, 86 (12), pp.2519-2529. ⟨10.1111/bcp.14362⟩
International audience; Aims: The objective was to compare major bleeding risk of direct oral anticoagulants (DOACs; per type and dose) with vitamin K antagonists (VKAs), irrespective of indication, using real-world data.Methods: A population-based p
Autor:
Jacques Bouget, Frédéric Balusson, Sandrine Kerbrat, Pierre-Marie Roy, Damien Viglino, Karine Lacut, Laure Pavageau, Emmanuel Oger
Publikováno v:
European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 2022, 78 (7), pp.1137-1144. ⟨10.1007/s00228-022-03318-x⟩
European Journal of Clinical Pharmacology, 2022, 78 (7), pp.1137-1144. ⟨10.1007/s00228-022-03318-x⟩
International audience; Purpose Low-dose parenteral anticoagulation has demonstrated its efficacy for venous thromboembolism prophylaxis in randomized trials. However, current practice is not widely documented. In ambulatory settings, we aimed to pro
Autor:
Karine Lacut, Marie-Clémence Huet, Emmanuel Oger, Pierre-Marie Roy, Laure Pavageau, Jacques Bouget, Damien Viglino
Publikováno v:
Thrombosis Research
Thrombosis Research, 2021, 199, pp.54-58. ⟨10.1016/j.thromres.2020.12.022⟩
Thrombosis Research, 2021, 199, pp.54-58. ⟨10.1016/j.thromres.2020.12.022⟩
International audience; BACKGROUND: There is little data on major muscular hematomas and the little there is has mainly focused on patients exposed to oral anticoagulants. OBJECTIVE: To describe the clinical characteristics, management and outcomes o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9adc15cb88faf6c7f0a5d3d0dece04f3
https://hal.archives-ouvertes.fr/hal-03129761
https://hal.archives-ouvertes.fr/hal-03129761
Autor:
Laure Pavageau, Jacques Bouget, Karine Lacut, Pierre-Marie Roy, Damien Viglino, Frédéric Balusson, Emmanuel Oger
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2020, 15 (8), pp.e0237022. ⟨10.1371/journal.pone.0237022⟩
PLoS ONE, Vol 15, Iss 8, p e0237022 (2020)
PLoS ONE, 2020, 15 (8), pp.e0237022. ⟨10.1371/journal.pone.0237022⟩
PLoS ONE, Public Library of Science, 2020, 15 (8), pp.e0237022. ⟨10.1371/journal.pone.0237022⟩
PLoS ONE, Vol 15, Iss 8, p e0237022 (2020)
PLoS ONE, 2020, 15 (8), pp.e0237022. ⟨10.1371/journal.pone.0237022⟩
International audience; Background - Major bleedings other than gastrointestinal (GI) and intracranial (ICH) and mortality rates associated with antiplatelet drugs in real-world clinical practice are unknown. The objective was to estimate major bleed
Autor:
Jacques Bouget, Maxime Maignan, Laure Pavageau, Frédéric Balusson, Pierre-Marie Roy, Lucie-Marie Scailteux, Emmanuel Nowak, Erwan L'Her
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2019, 33 (4), pp.443-462. ⟨10.1111/fcp.12444⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2019, 33 (4), pp.443-462. ⟨10.1111/fcp.12444⟩
Fundamental & Clinical Pharmacology, 2019, 33 (4), pp.443-462. ⟨10.1111/fcp.12444⟩
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2019, 33 (4), pp.443-462. ⟨10.1111/fcp.12444⟩
International audience; Bleeding represents the most recognized and feared complications of antithrombotic drugs including oral anticoagulants. Previous studies showed inconsistent results on the safety profile. Among explanations, bleeding definitio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd81c92bc38517040330c281363114a
https://univ-rennes.hal.science/hal-02020939
https://univ-rennes.hal.science/hal-02020939